Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 58, 2023 - Issue 11
Submit an article Journal homepage
81
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Is the prognosis of T1-2N1 colon cancer the same as that of T1-2N0 colon cancer after curative surgery?

Guangzhe Piana Department of Surgery, Ajou University School of Medicine, Suwon, South Korea;b Department of Surgery, Ajou University Graduate School of Medicine, Suwon, South Korea;c Department of Surgery, Yanbian University Hospital, Jilin, P.R. ChinaORCID Iconhttps://orcid.org/0000-0001-5343-4628View further author information
ORCID Icon &
Seung Yeop Oha Department of Surgery, Ajou University School of Medicine, Suwon, South KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7181-2538View further author information
ORCID Icon
Pages 1286-1294 | Received 27 Jan 2023, Accepted 04 Jun 2023, Published online: 22 Jun 2023

References

  • Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi: 10.1245/s10434-010-0985-4
  • Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi: 10.3322/caac.21388
  • Kim MJ, Jeong SY, Choi SJ, et al. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) Colon cancer. Ann Surg Oncol. 2015;22(2):505–512. doi: 10.1245/s10434-014-3982-1
  • Chu QD, Zhou M, Medeiros KL, et al. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) Colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. BMC Cancer. 2016;16:460. doi: 10.1186/s12885-016-2446-3
  • Lorenzon L, Balducci G, Ferri M. Sub-staging colorectal cancers and adjuvant treatments. J Am Coll Surg. 2015;220(3):379–381. doi: 10.1016/j.jamcollsurg.2014.12.005
  • André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–2351. doi: 10.1056/NEJMoa032709
  • Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322(6):352–358. doi: 10.1056/NEJM199002083220602
  • Brungs D, Aghmesheh M, de Souza P, et al. Safety and efficacy of oxaliplatin doublet adjuvant chemotherapy in elderly patients with stage III colon cancer. Clin Colorectal Cancer. 2018;17(3):e549–e555. doi: 10.1016/j.clcc.2018.05.004
  • Huang B, Mo S, Zhu L, et al. The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: an analysis of 12,036 patients in the SEER database. Oncotarget. 2016;7(48):79787–79796. doi: 10.18632/oncotarget.12970
  • Li J, Yi CH, Hu YT, et al. TNM staging of colorectal cancer should be reconsidered according to weighting of the T stage: verification based on a 25-year follow-up. Medicine (Baltimore). 2016;95(6):e2711. doi: 10.1097/MD.0000000000002711
  • Konishi T, Shimada Y, Lee LH, et al. Poorly differentiated clusters predict Colon cancer recurrence: an in-depth comparative analysis of invasive-front prognostic markers. Am J Surg Pathol. 2018;42(6):705–714. doi: 10.1097/PAS.0000000000001059
  • Kim S, Huh JW, Lee WY, et al. Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I Colon cancer recurrence. Int J Colorectal Dis. 2020;35(5):881–885. doi: 10.1007/s00384-020-03548-4
  • Zheng P, Chen Q, Li J, et al. Prognostic significance of tumor deposits in patients with stage III Colon cancer: a nomogram study. J Surg Res. 2020;245:475–482. doi: 10.1016/j.jss.2019.07.099.
  • Mukai M, Kishima K, Fukumitsu H, et al. Is the T1/2N1 (≤3 nodes) category actually stage IIIA (TNM)/IIIa (Japanese classification) in patients with primary colorectal cancer? Oncol Rep. 2011;26(1):209–214. doi: 10.3892/or.2011.1280
  • Douaiher J, Hussain T, Langenfeld SJ. Predictors of adequate lymph node harvest during colectomy for colon cancer. Am J Surg. 2019;218(1):113–118. doi: 10.1016/j.amjsurg.2018.08.020
  • Storli K, Søndenaa K, Furnes B, et al. Improved lymph node harvest from resected Colon cancer specimens did not cause upstaging from TNM stage II to III. World J Surg. 2011;35(12):2796–2803. doi: 10.1007/s00268-011-1248-7
  • Kim CW, Kim TW, Lee JL, et al. Controversial issues regarding obligatory adjuvant chemotherapy for stage IIIA colon cancer. Clin Colorectal Cancer. 2020;19(4):e157–e163. doi: 10.1016/j.clcc.2020.03.001
  • Park SY, Choi GS, Park JS, et al. Distinctive oncological features of stage IIIA colorectal cancer: analysis of prognostic factors for selective adjuvant chemotherapy. J Surg Oncol. 2015;111(7):882–890. doi: 10.1002/jso.23892

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.